首页> 外文期刊>Eyecare Business >Corporate Optometry Today
【24h】

Corporate Optometry Today

机译:公司验光今天

获取原文
           

摘要

Myopia is no longer just on ECPs’ radar. It’s a force to be dealt with. Numerous studies indicate that the prevalence of myopia is increasing in the U.S. and worldwide—and researchers project the trend will continue in the coming decades. In fact, projections suggest that almost 50% of the world will be myopic by 2050, according to the National Eye Institute. Besides simply representing a refractive change, myopia can lead to increased risk for more serious concerns such as retinal detachments, glaucoma, and macular degeneration. Treatment modalities include soft contact lenses, orthokeratology, glasses, and atropine.
机译:近视不再只是ECPS雷达。 这是一个待处理的力量。 许多研究表明,近视的患病率在美国和全球和研究人员项目中越来越多,将在未来几十年中持续下去。 事实上,根据国家眼部学院的说法,预测认为,2050年,世界的近50%将是近视。 除了仅仅代表屈光变化,近视可能导致更严重的担忧,如视网膜脱离,青光眼和黄斑变性的风险增加。 治疗方式包括软隐形眼镜,矫形器,眼镜和阿托品。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号